KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 123 filers reported holding KEROS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $23,830,128 | +39.3% | 521,447 | +101.8% | 0.00% | +33.3% |
| Q1 2024 | $17,103,961 | +109.7% | 258,368 | +26.0% | 0.00% | +50.0% |
| Q4 2023 | $8,154,736 | +155.6% | 205,099 | +105.0% | 0.00% | +100.0% |
| Q3 2023 | $3,189,881 | +7.4% | 100,059 | +35.4% | 0.00% | 0.0% |
| Q2 2023 | $2,969,583 | +11.7% | 73,907 | +18.7% | 0.00% | 0.0% |
| Q1 2023 | $2,658,502 | -62.0% | 62,260 | -57.3% | 0.00% | -50.0% |
| Q4 2022 | $7,002,373 | +105436.9% | 145,822 | -17.3% | 0.00% | 0.0% |
| Q3 2022 | $6,635 | +62.4% | 176,364 | +19.3% | 0.00% | +100.0% |
| Q2 2022 | $4,086 | -99.9% | 147,851 | +15.7% | 0.00% | 0.0% |
| Q1 2022 | $6,952,000 | -0.4% | 127,831 | +7.2% | 0.00% | 0.0% |
| Q4 2021 | $6,980,000 | +239.8% | 119,298 | +129.8% | 0.00% | – |
| Q3 2021 | $2,054,000 | +115.3% | 51,909 | +131.0% | 0.00% | – |
| Q2 2021 | $954,000 | +143.4% | 22,470 | +253.2% | 0.00% | – |
| Q1 2021 | $392,000 | -95.5% | 6,362 | -94.9% | 0.00% | -100.0% |
| Q4 2020 | $8,741,000 | +1179.8% | 123,915 | +599.4% | 0.00% | – |
| Q3 2020 | $683,000 | – | 17,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 292,833 | $17,134,000 | 5.65% |
| Deep Track Capital, LP | 1,300,000 | $76,063,000 | 5.37% |
| Octagon Capital Advisors LP | 340,214 | $19,906,000 | 3.87% |
| Opaleye Management Inc. | 265,750 | $15,549,000 | 3.30% |
| First Light Asset Management, LLC | 552,098 | $32,303,000 | 2.31% |
| Altium Capital Management LP | 116,000 | $6,787,000 | 1.87% |
| Nantahala Capital Management | 796,698 | $46,615,000 | 1.64% |
| Orbimed Advisors | 1,679,417 | $98,263,000 | 1.26% |
| Darwin Global Management, Ltd. | 111,500 | $6,524,000 | 1.00% |
| Parkman Healthcare Partners LLC | 69,861 | $4,088,000 | 0.90% |